Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from CardieX ( (AU:CDX) ).
Cardiex has successfully completed an institutional placement, raising $2.4 million by issuing over 60 million fully paid ordinary shares to institutional and sophisticated investors at $0.04 per share. The funds will be used for manufacturing, marketing, sales activities, and commercial expansion related to the CONNEQT Pulse device, enhancing Cardiex’s operational capacity and market positioning.
More about CardieX
Cardiex is a company focused on advancing medical technology for vascular health, offering products such as medical and home health devices, and digital solutions targeting hypertension, cardiovascular disease, and other vascular health disorders. Their technology is based on the SphygmoCor® vascular biomarker technology, and they are listed on the Australian Stock Exchange under the ticker ASX:CDX.
Average Trading Volume: 247,420
Technical Sentiment Signal: Sell
Current Market Cap: A$17.87M
For a thorough assessment of CDX stock, go to TipRanks’ Stock Analysis page.